Jeevan Patra | Drug Design | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jeevan Patra
National Institute of Technology, Rourkela

Jeevan Patra
Affiliation National Institute of Technology, Rourkela
Country India
Scholar ID n3bgLpAAAAAJ
Documents 35
Citations 323
h-index 6
Subject Area Drug Design
Event Global Academic Awards
ORCID 0000-0002-2709-4268

Jeevan Patra, a researcher affiliated with the National Institute of Technology, Rourkela, India. The profile summarizes publicly available academic indicators, research specialization, scholarly contributions, publication performance, and recognition within the field of Drug Design. The article follows a neutral, encyclopedia-inspired presentation intended for academic recognition and reference.[1]

Abstract

Jeevan Patra has developed research interests centered on Drug Design and associated interdisciplinary biomedical sciences. Available scholarly indicators demonstrate sustained publication activity supported by peer-reviewed research outputs and measurable citation impact. The profile illustrates an active contribution to scientific literature and highlights engagement with contemporary pharmaceutical and molecular research topics.[1][2]

Keywords

Drug Design, Computational Drug Discovery, Medicinal Chemistry, Pharmaceutical Research, Molecular Modeling, Bioinformatics, Chemical Biology, Structure-Based Drug Design, Academic Research, Scientific Publications.

Introduction

Drug Design represents an essential research discipline supporting the discovery and optimization of therapeutic compounds through experimental and computational methodologies. Researchers working in this area contribute to advances in medicinal chemistry, molecular pharmacology, and pharmaceutical development. Academic performance is commonly evaluated through publication records, citation metrics, collaboration networks, and contributions to innovation.[3]

Research Profile

Jeevan Patra is affiliated with the National Institute of Technology, Rourkela, India. Publicly available scholarly metrics indicate approximately 35 indexed research documents with more than 323 citations and an h-index of 6. These indicators reflect continued participation in scholarly publishing and ongoing contributions to research related to Drug Design and associated biomedical disciplines.[1]

Research Contributions

The available publication record demonstrates involvement in multidisciplinary investigations supporting pharmaceutical innovation, computational chemistry, molecular interactions, and drug discovery strategies. Research contributions emphasize scientific rigor, peer-reviewed dissemination, and collaboration across complementary scientific domains.[2]

  • Drug discovery methodologies.
  • Medicinal chemistry research.
  • Computational molecular analysis.
  • Scientific collaboration and publication.

Publications

The research portfolio consists of peer-reviewed journal publications indexed by major scholarly databases. Publications collectively demonstrate continuing academic engagement in pharmaceutical sciences and computational approaches for therapeutic development.[2]

  • Approximately 35 scholarly publications.
  • Citation count exceeding 323.
  • Research indexed within recognized academic databases.

Research Impact

Citation metrics and publication activity indicate measurable scholarly visibility within the Drug Design research community. Citation-based indicators, together with publication consistency, suggest that the research has contributed to ongoing scientific discussions and knowledge development in pharmaceutical sciences.[1]

Award Suitability

Based on publicly available scholarly indicators, Jeevan Patra demonstrates characteristics commonly considered during academic recognition processes, including peer-reviewed publications, citation performance, research productivity, and contributions within the field of Drug Design. Final award decisions remain dependent upon the formal evaluation criteria established by the Global Academic Awards and supporting documentation submitted by the nominee.[4]

Conclusion

The academic profile presented here summarizes available bibliometric information together with an overview of scholarly activities in Drug Design. Through peer-reviewed publications, citation performance, and institutional affiliation, the profile reflects sustained participation in scientific research while providing an objective reference suitable for academic recognition documentation.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Jeevan Patra.
    https://scholar.google.com/citations?user=n3bgLpAAAAAJ&hl=en
  2. Crossref DOI Foundation. (n.d.). Digital Object Identifier System.
    https://doi.org/10.1038/nrd.2017.203
  3. Computational Design of Pyrazole Derivatives for Management of Autoimmune Disease. https://link.springer.com/chapter/10.1007/978-3-032-12320-6_8
  4. Global Academic Awards. (n.d.). Award nomination information.
    https://globalacademicawards.com/

Jaber Salehzadeh | Organic Synthesis | Research Excellence Award

Published on by Global Academic Awards

Research Excellence Award

Jaber Salehzadeh
Provincial Water and Sewage Company, Iran

Jaber Salehzadeh
Affiliation Provincial Water and Sewage Company
Country Iran
Scholar ID fhaf0jMAAAAJ
Documents 24
Citations 310
h-index 9
Subject Area Organic Synthesis
Event Global Academic Awards

Jaber Salehzadeh has established an academic profile supported by publications, citations, and interdisciplinary research interests. Although affiliated with the Provincial Water and Sewage Company, the available scholarly record indicates research activity relevant to Organic Synthesis and related scientific applications. The available Google Scholar metrics indicate an active publication history with twenty-four documents, more than three hundred citations, and an h-index of nine.[1]

Abstract

Jaber Salehzadeh is a researcher associated with the Provincial Water and Sewage Company in Iran. According to the publicly available Google Scholar profile, the researcher has produced twenty-four scholarly publications that have collectively received more than three hundred citations, resulting in an h-index of nine. The documented publication record reflects continued scientific engagement in Organic Synthesis and associated interdisciplinary research areas, demonstrating a measurable academic presence through peer-reviewed research and scholarly dissemination.[1]

Keywords

Organic Synthesis, Synthetic Chemistry, Chemical Research, Reaction Engineering, Molecular Design, Green Chemistry, Scientific Publications, Research Excellence, Chemical Innovation, Academic Recognition.

Introduction

Organic Synthesis remains one of the foundational disciplines within modern chemistry, supporting discoveries across pharmaceuticals, materials science, catalysis, agriculture, and environmental technologies. Advances in synthetic methodologies continue to improve reaction efficiency, molecular complexity, sustainability, and industrial scalability. Researchers working in this field contribute to expanding chemical knowledge through innovative reaction pathways, characterization techniques, and practical applications that influence numerous scientific disciplines.[2]

Research Profile

The publicly available Google Scholar profile indicates that Jaber Salehzadeh has established a sustained publication record with twenty-four indexed scholarly works receiving approximately three hundred ten citations. The resulting h-index of nine reflects consistent citation activity across multiple publications. These indicators demonstrate continuing scholarly participation and measurable academic visibility within the research community.[1]

  • Affiliation: Provincial Water and Sewage Company
  • Country: Iran
  • Google Scholar Publications: 24
  • Total Citations: 310
  • h-index: 9

Research Contributions

The available scholarly profile suggests contributions involving Organic Synthesis and chemically related research. Research in this area commonly supports the development of efficient synthetic strategies, improved catalytic systems, environmentally responsible reaction processes, and the preparation of compounds with potential scientific and industrial significance. Such work contributes to expanding the broader knowledge base of modern chemistry.[2]

Publications

The documented publication portfolio demonstrates continued scholarly productivity through peer-reviewed research articles. Citation activity indicates that the published work has been referenced by other researchers, providing evidence of academic engagement and contribution to ongoing scientific discussions within chemistry and related disciplines.[1]

  • Twenty-four documented scholarly publications.
  • Research involving Organic Synthesis and related chemical sciences.
  • Peer-reviewed scientific dissemination supporting ongoing academic research.

Research Impact

Citation metrics provide quantitative evidence of scholarly influence. With approximately three hundred ten citations and an h-index of nine, the available academic indicators demonstrate that the published work has received recognition within the scientific community. These metrics represent measurable research visibility and continuing academic relevance.[1]

Award Suitability

Based on the documented scholarly metrics and publication record, Jaber Salehzadeh demonstrates characteristics frequently considered during academic recognition programs, including sustained research productivity, measurable citation performance, and continued scientific contributions. These documented achievements support consideration for the Research Excellence Award presented through the Global Academic Awards while acknowledging that award decisions depend upon the complete evaluation criteria established by the organizing committee.[1]

Conclusion

Jaber Salehzadeh has developed a documented scholarly profile characterized by peer-reviewed publications, measurable citation impact, and continued engagement in Organic Synthesis research. The available publication metrics demonstrate sustained academic participation and an established record of scientific contribution. Continued research productivity and scholarly collaboration are expected to further strengthen future academic impact within the broader chemical sciences community.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Jaber Salehzadeh, Scholar ID fhaf0jMAAAAJ.
    https://scholar.google.com/citations?user=fhaf0jMAAAAJ&hl=en&oi=sra
  2. Carey, F. A., & Sundberg, R. J. Advanced Organic Chemistry.
    DOI: https://doi.org/10.1007/978-0-387-44899-2
  3. A study on fractality properties of nano particles scanning electron microscopy images
    https://ljs.academicdirect.org/A25/111_116.htm

Jing-Ru Weng | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Best Researcher Award

Jing-Ru Weng
National Sun Yat-sen University

Jing-Ru Weng
Affiliation National Sun Yat-sen University
Country Taiwan
Scopus ID 7202292078
Documents 109
Citations 3,975
h-index 33
Subject Area Pharmacology
Event Global Academic Awards

Jing-Ru Weng, a researcher affiliated with National Sun Yat-sen University in Taiwan. The award evaluation considers publication productivity, citation impact, research visibility, and contributions to pharmacology and biomedical sciences. The researcher’s academic portfolio demonstrates a consistent record of peer-reviewed scientific output and measurable influence within the international research community.[1]

Abstract

This academic article provides a structured overview of the scholarly profile, research performance, and scientific contributions of Jing-Ru Weng in the field of pharmacology. The article summarizes publication activity, citation metrics, research impact, and academic recognition associated with the Best Researcher Award presented through the Global Academic Awards platform. The researcher’s profile reflects sustained engagement in pharmacological sciences and biomedical investigation supported by extensive peer-reviewed scholarly output.[1]

Keywords

Pharmacology, biomedical research, drug discovery, scientific publications, citation analysis, academic awards, translational medicine, pharmacological sciences, research impact, scholarly recognition.

Introduction

Academic recognition programs are designed to acknowledge researchers whose work has demonstrated measurable scientific influence and sustained scholarly engagement. The Best Researcher Award evaluates research productivity, publication quality, citation performance, and contribution to scientific advancement across specialized disciplines.[2]

Jing-Ru Weng has established an academic profile characterized by extensive publication activity and significant citation visibility within pharmacology and related biomedical sciences. The researcher’s work contributes to ongoing developments in pharmacological research, therapeutic investigation, and translational biomedical applications.[1]

Research Profile

Jing-Ru Weng is affiliated with National Sun Yat-sen University in Taiwan. The Scopus-indexed research profile includes 109 scholarly documents, nearly four thousand citations, and an h-index of 33, indicating broad academic influence and sustained citation engagement across multiple publications.[1]

  • Affiliation with National Sun Yat-sen University.
  • Research specialization in pharmacology and biomedical sciences.
  • Extensive peer-reviewed publication record.
  • Strong citation performance within indexed scientific literature.

Research Contributions

The researcher’s scientific contributions are associated with pharmacological investigation, therapeutic development, molecular research, and translational biomedical science. Such work contributes to understanding disease mechanisms, evaluating therapeutic compounds, and advancing evidence-based pharmacological applications.[3]

The citation impact associated with the researcher’s publications indicates broad academic engagement and relevance within the pharmacology community. Citation metrics are commonly used to evaluate research dissemination and scientific influence within biomedical disciplines.

  • Pharmacological and molecular biomedical research.
  • Scientific investigation related to therapeutic strategies.
  • Publication in internationally indexed journals.
  • Contribution to translational and evidence-based medicine.

Publications

The publication portfolio associated with Jing-Ru Weng reflects substantial research engagement within pharmacology and biomedical science. Representative research themes include therapeutic development, molecular pharmacology, and translational biomedical investigation.

  1. Research articles related to pharmacological mechanisms and therapeutic compounds.
  2. Biomedical studies addressing translational medicine applications.
  3. Collaborative scientific publications in peer-reviewed journals.
  4. Studies contributing to evidence-based pharmacological science.

Research Impact

Research impact is commonly assessed through publication consistency, citation frequency, and interdisciplinary visibility. The academic metrics associated with Jing-Ru Weng indicate sustained scientific engagement and broad dissemination of research findings across pharmacology and biomedical literature.[1]

The h-index value reflects the combined influence of multiple highly cited publications and demonstrates continuing scholarly relevance within pharmacological research. Such bibliometric indicators are frequently referenced in institutional evaluations, grant assessments, and academic recognition frameworks.

Award Suitability

The Best Researcher Award emphasizes excellence in scientific productivity, citation influence, publication quality, and research contribution within specialized academic disciplines. Based on the available bibliometric indicators and scholarly record, Jing-Ru Weng demonstrates qualifications consistent with recognized standards of academic distinction in pharmacology and biomedical sciences.[2]

  • Extensive publication record within indexed databases.
  • Strong citation metrics and measurable research visibility.
  • Contribution to pharmacological and biomedical advancement.
  • Demonstrated engagement in peer-reviewed scientific communication.

Conclusion

The academic profile of Jing-Ru Weng reflects substantial scholarly engagement within pharmacology and biomedical science. Publication productivity, citation impact, and research visibility collectively support recognition through the Best Researcher Award under the Global Academic Awards platform. The profile demonstrates sustained contribution to scientific advancement, scholarly communication, and translational biomedical investigation.[1]

References

    1. Elsevier. (n.d.). Scopus author details: Jing-Ru Weng, Author ID 7202292078. Scopus.https://www.scopus.com/authid/detail.uri?authorId=7202292078
    2. Journal of Medicinal Chemistry. (2007). Pharmacological investigations and therapeutic compound development.
    3. Molecular Cancer Therapeutics. (2009). Biomedical research impact and translational pharmacology.https://doi.org/10.1158/1535-7163.MCT-09-0168

Ping Wang | Drug Discovery | Research Excellence Award

Published on by Global Academic Awards

Prof. Dr. Ping Wang | Drug Discovery | Research Excellence Award

Shanghai University of Traditional Chinese Medicine | China

Prof. Dr. Ping Wang is a leading researcher in pharmacology, biochemistry, and molecular medicine, with a strong focus on natural products, enzyme regulation, metabolic diseases, and cancer therapeutics. He has authored over 80 high-quality Scopus-indexed publications, receiving more than 2,541 citations and achieving an h-index of 28, reflecting sustained scientific impact. His work integrates traditional Chinese medicine with modern drug discovery, chemical biology, and molecular mechanisms, including studies on COMT, metabolic reprogramming, obesity, liver diseases, and antiviral agents. Publications in top-tier journals such as Cell Metabolism, Journal of Medicinal Chemistry, and Acta Pharmaceutica Sinica B highlight his international research excellence and translational significance.

Citation Metrics (Scopus)

3000

2400

1800

1200

600

0

Citations 2,541

Documents 83

h-index
28

■ Citations
■ Documents
■ h-index


View Scopus Profile

Featured Publications

Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Published on by Global Academic Awards

Dr. Mohammad Sadegh Taghizadeh | Drug Discovery | Best Researcher Award

Shiraz University | Iran

Dr. Mohammad Sadegh Taghizadeh is a highly accomplished researcher at the Institute of Biotechnology, whose work centers on bioactive peptides, protein hydrolysates, structure-based drug design, encapsulation, and natural product research. His research integrates experimental biology, molecular docking, and dynamic simulation to uncover new therapeutic agents and improve bioavailability in peptide-based drug delivery systems. He has made significant contributions to understanding peptide–receptor interactions, anticancer bioactives, and sustainable biotechnological production, with influential publications in prestigious journals such as PLOS One, Scientific Reports, npj Science of Food, and Critical Reviews in Biotechnology. His innovative studies on cyclotide ligands, oral delivery systems, and plant-based bioactive compounds have advanced the fields of pharmaceutical biotechnology and functional food science, earning him strong citation impact and scholarly recognition. In addition to his research, Dr. Mohammad Sadegh Taghizadeh has served as a keynote speaker and workshop lecturer, contributing to scientific capacity-building in molecular biology, computational modeling, and peptide biochemistry, reflecting his leadership and excellence in modern biotechnology research.

Profile: Google Scholar

Featured Publications

  • Taghizadeh, M. S., Niazi, A., Moghadam, A., & Afsharifar, A. (2022). Experimental, molecular docking and molecular dynamic studies of natural products targeting overexpressed receptors in breast cancer. PLOS ONE, 17(5), e0267961.

  • Mirzapour-Kouhdasht, A., McClements, D. J., Taghizadeh, M. S., Niazi, A., & others. (2023). Strategies for oral delivery of bioactive peptides with focus on debittering and masking. npj Science of Food, 7(1), 22.

  • Mirzapour-Kouhdasht, A., Sabzipour, F., Taghizadeh, M. S., & others. (2019). Physicochemical, rheological, and molecular characterization of colloidal gelatin produced from common carp by-products using microwave and ultrasound-assisted extraction. Journal of Texture Studies, 50(5), 416–425.

  • Taghizadeh, M. S., Retzl, B., Muratspahić, E., Trenk, C., Casanova, E., & Gruber, C. W. (2022). Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor. Scientific Reports, 12(1), 9215.

  • Shahraki, Z., Taghizadeh, M. S., Niazi, A., Rowshan, V., & Moghadam, A. (2024). Enhancing bioactive compound production in Salvia mirzayanii through elicitor application: Insights from in vitro and in silico studies. Food Bioscience, 60, 104185.

Jing Nie | Medicinal Chemistry | Best Researcher Award

Published on by Global Academic Awards

Ms. Jing Nie | Medicinal Chemistry | Best Researcher Award

Ms. Jing Nie | Shandong Second Provincial General Hospital | China

Ms. Jing Nie serves as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital and holds the position of Associate Chief Pharmacist. She actively contributes to the advancement of pharmaceutical sciences through her leadership roles in various professional committees, including the Shandong Provincial Hospital Association’s Digital and Intelligent Pharmacy Committee, the Pediatric Rational Drug Use Committee of the Shandong Pharmacists Association, and the Otolaryngology Pharmacy Committee of the Shandong Pharmaceutical Society. She is also a core member of the Rheumatology Committee of the Jinan Association of Integrated Traditional Chinese and Western Medicine, the Antitumor Drug Committee of the Shandong Pharmaceutical Society, the Tumor Pharmacy Branch of the Shandong Anti-Cancer Association, and the Internet Plus Pharmacy Services Committee. Her research focuses on hospital pharmacy, artificial intelligence, pharmacoeconomics, and antitumor drug development. She has published extensively, secured patents, developed software, and led multiple provincial and collaborative projects while contributing to numerous national-level studies.

Publication Profile

Scopus

Education

Ms. Jing Nie earned her doctoral degree in pharmacy, equipping her with a strong academic foundation to contribute to both scientific research and clinical pharmacy practice. Her education combined rigorous theoretical learning with extensive research experience, allowing her to specialize in the integration of hospital pharmacy with advanced technologies such as artificial intelligence and pharmacoeconomics. During her doctoral training, she focused on evidence-based approaches to optimize drug therapy and explored the mechanisms and applications of antitumor drugs. Her academic journey not only strengthened her technical expertise but also instilled in her a deep commitment to innovation, patient safety, and rational drug use. She has built upon her formal education through continuous professional development, actively engaging with academic societies, conferences, and specialized committees that broaden her knowledge and keep her at the forefront of evolving pharmaceutical sciences. Her educational background remains the cornerstone of her contributions to research and practice.

Experience

Ms. Jing Nie has extensive professional experience as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital, where she also serves as Associate Chief Pharmacist. Her experience includes leadership and active participation in multiple prestigious committees, such as those dedicated to digital pharmacy, rational pediatric drug use, otolaryngology pharmacy, rheumatology, and oncology. She has played a key role in advancing pharmaceutical sciences by bridging hospital pharmacy with innovative fields like artificial intelligence and pharmacoeconomics. Her experience is further reflected in her strong publication record, where she has authored and co-authored more than twenty scientific papers, many in high-impact journals. She has successfully applied her expertise to provincial-level projects, cross-disciplinary collaborations, and has contributed significantly to national-level studies. In addition, her practical work includes obtaining multiple patents and software copyrights, reinforcing her ability to translate scientific innovation into practical applications that benefit patients and the healthcare system.

Research Focus

Ms. Jing Nie’s research focus lies at the intersection of pharmaceutical sciences, oncology, and innovative therapeutic strategies. Her work on the advances of HDAC dual inhibitors in breast cancer treatment highlights her commitment to exploring novel drug mechanisms and targeted therapies in oncology. By investigating epigenetic regulation through HDAC inhibition, she contributes to the development of more effective treatments for breast cancer patients, bridging basic research with clinical applications. Beyond oncology, her broader focus includes hospital pharmacy, pharmacoeconomics, artificial intelligence in drug management, and rational drug use. This multidisciplinary approach allows her to integrate clinical practice with cutting-edge research, addressing both the economic and therapeutic aspects of patient care. Her emphasis on anti-tumor drug development, combined with her role in scientific committees and leadership positions, reflects a holistic vision of improving healthcare outcomes through innovation, collaboration, and translational research. Ms. Nie’s focus is well aligned with advancing precision medicine and modern pharmacy.

Publication Top Notes

Advances of HDAC dual inhibitors in breast cancer treatment

Conclusion

Ms. Jing Nie is highly suitable for the Research for Best Researcher Award, given her impactful contributions to pharmaceutical sciences, leadership roles, and innovation in anti-tumor drug research and artificial intelligence. With strategic international engagement and clinical translation of her work, she has the potential to become a globally recognized leader in hospital pharmacy research.

Zhao Lichun | Pharmacology | Best Researcher Award

Published on by Global Academic Awards

Prof. Dr. Zhao Lichun | Pharmacology | Best Researcher Award

Prof. Dr. Zhao Lichun | Guiyang College of Traditional Chinese Medicine | China

Prof. Dr. Zhao Lichun, an esteemed scholar from Changchun, Jilin Province, China, has established himself as a leading researcher in the fields of trace elements and traditional Chinese medicine. With a Ph.D. and postdoctoral fellowship at Hong Kong Baptist University, he currently serves as a researcher, doctoral supervisor, and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. Additionally, he is the executive editor-in-chief of Trace Elements and Health Research, Director of Guizhou Laboratory, and Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. Widely recognized for his academic leadership, he has introduced pioneering concepts such as “elemental traditional Chinese medicine” and identified rubidium as a key trace element essential for human health. His prolific contributions include over two hundred publications, numerous patents, and national awards, positioning him as a trailblazer in scientific innovation and healthcare advancement.

Publication Profile

Scopus

Education

Prof. Zhao Lichun’s academic journey reflects a deep commitment to scientific research and medical innovation. He earned his doctoral degree in China, focusing on the intersection of trace elements and traditional Chinese medicine, and subsequently pursued a prestigious postdoctoral fellowship at Hong Kong Baptist University. His training allowed him to integrate modern scientific methods with traditional medicine, bridging ancient knowledge with contemporary biomedical research. Throughout his academic development, he consistently explored how trace elements influence human health, leading him to propose novel concepts such as “elemental traditional Chinese medicine.” His interdisciplinary education provided him with a strong foundation in chemistry, medicine, and health sciences, which has shaped his groundbreaking contributions to the study of essential trace elements like rubidium. By combining rigorous scientific inquiry with innovative theoretical frameworks, Prof. Zhao has become a recognized academic leader whose educational background underpins his extensive research achievements.

Experience

Prof. Zhao Lichun has accumulated extensive professional experience across research, teaching, leadership, and editorial roles. He serves as a doctoral supervisor and Director of the Research Department and Center for Trace Elements and Health Development at Guizhou University of Chinese Medicine. In addition, he leads the Guizhou Laboratory and the Guangxi Key Laboratory for the Development of Endangered Medicinal Materials Resources. As executive editor-in-chief of Trace Elements and Health Research, he plays a key role in advancing scholarly communication. His influence extends to national-level scientific initiatives, serving as a project evaluation expert for the China National Science and Technology Award, National Key R&D Program, and the National Natural Science Foundation. With leadership positions in professional associations related to health medicine, big data, artificial intelligence, diet research, and elderly healthcare, Prof. Zhao combines academic rigor with institutional guidance, contributing to both innovation and policy development.

Research Focus

Prof. Dr. Zhao Lichun’s research focus lies at the intersection of trace element science, traditional Chinese medicine, and modern biomedical innovation. His work emphasizes the critical roles of elements such as copper, iron, zinc, selenium, rubidium, silicon, chromium, and vanadium in human health, with particular attention to their involvement in neurodegenerative diseases like Alzheimer’s. He has pioneered the concept of “elemental traditional Chinese medicine,” exploring how minerals and trace elements can be harnessed for therapeutic benefits in chronic conditions, cancer, inflammatory diseases, and metabolic disorders. His studies highlight the mechanisms of action of compounds such as rosmarinic acid in cancer cell regulation, the protective effects of rubidium salts in ulcerative colitis, and the role of traditional medicine in enhancing recovery in chronic rhinosinusitis. Additionally, he explores nanomaterials and enzyme microreactors to improve therapeutic stability and efficiency. His multidisciplinary approach integrates pharmacology, molecular biology, and clinical applications to advance healthcare innovation.

Publication Top Notes

  • Bacteriostatic activity and mechanism of minerals containing rubidium
    Year: 2025

  • Traditional Chinese medicine in chronic rhinosinusitis: Mechanisms and postoperative recovery
    Year: 2025 | Citations: 3

  • Rosmarinic acid promotes mitochondrial fission and induces ferroptosis in triple-negative breast cancer cells
    Year: 2025 | Citations: 13

  • Interfacial Stabilization through MOF-Polymer Core-Shell Design: Ultraefficient, Stable and Recyclable Enzymatic Microreactors
    Year: 2025

  • Rubidium salt can effectively relieve the symptoms of DSS-induced ulcerative colitis
    Year: 2024 | Citations: 22

Conclusion

Prof. Zhao Lichun’s outstanding academic achievements, innovative research contributions, and leadership in advancing traditional Chinese medicine and trace element science make him a strong candidate for the Research for Best Researcher Award. With further international expansion of his research collaborations and recognition, he is well-positioned to become a truly global authority in his field.

SooHo Yeo | Medicinal Chemistry | Best Researcher Award

Published on by Global Academic Awards

Dr. SooHo Yeo | Medicinal Chemistry | Best Researcher Award

Research Professor from Yonsei University College of Pharmacy | South Korea

Dr. SooHo Yeo is a distinguished pharmaceutical researcher specializing in pharmaceutics, nanomedicine, and photodynamic cancer therapy. He earned his M.S./Ph.D. from the College of Pharmacy at Chung-Ang University, Seoul, Korea, with a dissertation focused on artificial skin formulation for the topical delivery of adenosine. Currently serving as a Research Professor at Yonsei University, he previously held a similar position at INJE University’s Department of Nanoscience and Engineering. Dr. Yeo’s expertise spans nano/micro-particle drug delivery, solid lipid nanoparticles, liposomes, and cosmetic dermatology. His work includes in vitro toxicology, pharmacokinetic/pharmacodynamic analysis, and OECD-guideline-based skin testing. He has published extensively in top-tier journals such as ACS Omega, Scientific Reports, International Journal of Pharmaceutics, and Pharmaceutics, with research focused on enhancing anticancer efficacy through innovative nanoparticle systems. Dr. Yeo is widely recognized for his interdisciplinary contributions that merge pharmaceutical sciences, biomedical engineering, and clinical research.

Publication Profile

Orcid

Academic Background

Dr. SooHo Yeo earned his M.S./Ph.D. degree from the prestigious College of Pharmacy at Chung-Ang University, located in Seoul, Korea. His academic journey reflects a strong foundation in pharmaceutical sciences, with a focus on drug delivery systems and dermal formulations. His doctoral research, titled “Artificial Skin Formulation for Topical Delivery of Adenosine,” showcases his early commitment to developing innovative therapeutic approaches using transdermal delivery platforms. The dissertation centered on the design and optimization of artificial skin systems to enhance the bioavailability and therapeutic impact of adenosine, a bioactive compound with potential in cosmetic and pharmaceutical applications. This research not only demonstrated Dr. Yeo’s technical expertise in pharmaceutics and cosmeceutics but also laid the groundwork for his later contributions to nanomedicine and photodynamic therapy. His education at Chung-Ang University provided a solid interdisciplinary foundation that continues to shape his impactful research in pharmaceutical innovation.

Professional Experience

Dr. SooHo Yeo has held prominent research positions that underscore his expertise in pharmaceutical sciences and nanotechnology. he has been serving as a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea, where he contributes to cutting-edge research in drug delivery systems, photodynamic therapy, and cosmetic formulation development. Prior to this role, Dr. Yeo worked as a Research Professor in the Department of Nanoscience and Engineering at INJE University in Gimhae, Korea. During his tenure at INJE University, he focused on advanced nanomaterials for biomedical applications, integrating nanoscience with pharmacological innovation. His work at both institutions reflects a consistent dedication to interdisciplinary research, bridging pharmaceutical development with nanotechnology and bioengineering. Dr. Yeo’s professional experience highlights his active role in advancing therapeutic strategies through nanomedicine and solidifies his reputation as a leading figure in pharmaceutical and cosmetic research in South Korea.

Research Focus

Dr. SooHo Yeo’s research is firmly rooted in pharmaceutical sciences, with a specialized focus on nanomedicine, drug delivery systems, and photodynamic therapy for cancer treatment. His work centers on the development of advanced nanoformulations such as solid lipid nanoparticles, nanostructured lipid carriers, and lipid-based vesicles to enhance the therapeutic efficacy of anti-cancer agents like purpurin derivatives, doxorubicin, aspirin, and curcumin. A major theme in his research is topical and transdermal delivery systems using biocompatible polymers like hydroxypropyl methylcellulose for treating skin cancer. He also explores emulsion gels, pH-responsive nanocarriers, and cosmeceutical applications to treat or prevent conditions like postoperative adhesions and dermatological issues. His studies include in vitro and in vivo evaluations, highlighting a strong translational approach. Through consistent contributions to peer-reviewed journals, Dr. Yeo has positioned himself at the forefront of targeted drug delivery, phototherapy, and pharmaceutical nanotechnology aimed at improving patient outcomes in oncology and dermatology.

Publication Top Notes

  • Preparation and evaluation of hydroxypropyl methylcellulose‐based film incorporated with aspirin‐loaded solid lipid nanoparticles to treat skin cancer
    Year: 2025

  • Development of nanostructured lipid carriers loaded with purpurin-18 N propargylimide methyl ester to improve photodynamic therapy
    Year: 2025

  • Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester
    Year: 2025

  • A Celecoxib-Loaded Emulsion Gel for Enhanced Drug Delivery and Prevention of Postoperative Adhesion
    Year: 2025

  • Encapsulation of synthesized purpurin-18-N-aminoimide methyl ester in lipid nanovesicles for use as agents in photodynamic cancer therapy
    Year: 2025

Conclusion

Dr. SooHo Yeo is a highly qualified candidate for the Research for Best Researcher Award. His cutting-edge work in nanoparticle-based drug delivery systems, photodynamic therapy, and cosmeceutical formulations, combined with an impressive publication record and solid research positions, positions him as a frontrunner in pharmaceutical sciences. While metrics on citations and translational outcomes could further bolster his candidacy, his depth of expertise, innovation, and interdisciplinary application make him strongly suitable for this award.

 

Fatma Moharram | Biological Activity | Best Researcher Award

Published on by Global Academic Awards

Prof. Fatma Moharram | Biological Activity | Best Researcher Award

Prof. Fatma Moharram at Helwan University, Egypt

Fatma Abdel Kader Mohamed Moharram is a distinguished professor and researcher in Pharmacognosy with extensive academic and research experience. She has held prominent positions at esteemed institutions, including Helwan University, King Faisal University, and Taibahu University. Her expertise spans natural products chemistry, medical education, and biological evaluation of plant extracts. As a department head and vice dean, she has played a pivotal role in academic leadership. With numerous publications, editorial memberships, and conference participations, she has significantly contributed to pharmaceutical sciences, mentoring many postgraduate students and advancing research in pharmacognosy and phytochemistry.

Publication Profile

Orcid

Educational Background🎓

Fatma Moharram holds a Ph.D. in Pharmaceutical Sciences (Pharmacognosy) from Cairo University (1996), focusing on the phytochemical and biological study of Cordia species. She earned an M.Sc. in Pharmaceutical Sciences from Cairo University (1992) with research on Melaleuca species and a B.Pharm.Sc. from the same institution. Additionally, she completed an M.Sc. in Medical Education through a distance learning program between Suez Canal and Maastricht Universities. Her multidisciplinary education has provided her with a strong foundation in pharmacognosy, natural product chemistry, and medical education, shaping her extensive research and teaching career across multiple institutions worldwide.

Professional background👩‍🏫

With over three decades in academia, Fatma Moharram has served as a professor, researcher, and administrator. She worked at the National Research Centre (Egypt), Helwan University, King Faisal University, and Taibahu University. She led departments, supervised numerous postgraduate theses, and played key roles in medical education. As Vice Dean for Community Service and Environment Development (2017-2021), she spearheaded initiatives enhancing educational effectiveness. Her international experience includes a postdoctoral fellowship at Humboldt University and editorial roles in global pharmaceutical journals. She has contributed significantly to pharmacognosy education, research projects, and curriculum development across multiple universities.

Awards and Honors🏆

Fatma Moharram has received numerous accolades for her contributions to pharmacognosy and medical education. She has been recognized for her impactful research, leadership in academic development, and participation in international scientific conferences. As a reviewer for prestigious journals and promotion committees, she has influenced pharmaceutical research globally. She has also played a pivotal role in research projects funded through international collaborations. Her leadership in organizing and chairing conferences at Helwan University, Al-Azhar University, and beyond has cemented her reputation as a key figure in pharmacognosy and natural product sciences.

Research Focus🔬

Fatma Moharram specializes in pharmacognosy and the chemistry of natural products, particularly the isolation and identification of bioactive compounds from plants and endophytes. Her research explores essential oils, polyphenols, and flavonoids, with applications in pharmaceuticals and medicine. She has led studies on biological evaluations of plant extracts for antimicrobial, antioxidant, and anti-inflammatory properties. Her expertise extends to chromatography, spectroscopy, and biosynthesis, contributing to drug discovery. As a reviewer and editor for international journals, she continuously advances research in phytochemistry, ethnopharmacology, and medicinal plant sciences, bridging traditional medicine with modern pharmaceutical applications.

Publication Top Notes

1️⃣ Comprehensive Assessment of the Antidiarrheal Properties of Polyphenols from Psidium cattleianum Sabine’s Aerial Parts 📖
Year: 2025 | Journal: Journal of Ethnopharmacology

2️⃣ Bioactive Metabolites Identified from Aspergillus terreus Derived from Soil 🦠
Year: 2023 | Journal: AMB Express

3️⃣ Melaleuca rugulosa (Link) Craven Tannins: Appraisal of Anti-inflammatory, Radical Scavenging Activities, and Molecular Modeling Studies 🌿
Year: 2022 | Journal: Journal of Ethnopharmacology

Conclusion

Fatma Abdel Kader Mohamed Moharram is a distinguished researcher and academic with extensive expertise in Pharmacognosy, natural product chemistry, and medical education. Holding a Ph.D. in Pharmaceutical Science and multiple academic positions at prestigious institutions like Helwan University, King Faisal University, and Taibahu University, she has made significant contributions to research and education. Her work includes isolating and identifying bioactive compounds, analyzing essential oils, and evaluating plant extracts’ biological properties. With numerous publications, active participation in international conferences, leadership roles, editorial contributions to renowned journals, and supervision of MSc and Ph.D. theses, she has demonstrated exceptional academic influence and research impact. As a reviewer for various research projects and promotions, she upholds high research standards, making her a highly deserving candidate for the Best Researcher Award.

 

 

Neda Shakour | Medicinal chemistry | Best Researcher Award

Published on by Global Academic Awards

Dr. Neda Shakour | Medicinal chemistry | Best Researcher Award

Dr. Neda Shakour, Mashhad University of Medical Science, Iran

Dr. Neda Shakour is a distinguished medicinal chemist at Mashhad University of Medical Sciences, specializing in drug design for diabetes treatment. With a Ph.D. in Medicinal Chemistry, her research focuses on thiazolidinediones and in silico drug discovery. She has extensive teaching experience and has contributed to regulatory work at the Food and Drug Administration of Mashhad. Recognized with numerous awards and research grants, Dr. Shakour has published extensively on cancer therapies, metabolic diseases, and nanomedicine, making significant advancements in medical science. 🏆🔬

Publication Profile

Google Scholar

🎓 Education

Dr. Neda Shakour earned her Ph.D. in Medicinal Chemistry from Mashhad University of Medical Sciences, focusing on designing and synthesizing novel thiazolidinediones for diabetes treatment. She completed her M.Sc. in Organic Chemistry at the University of Zanjan, where she specialized in nanoscale compound synthesis. Her academic journey began with a B.Sc. in Chemistry from Islamic Azad University of Shahreza. Throughout her studies, Dr. Shakour demonstrated exceptional research capabilities, gaining recognition for her contributions to medicinal chemistry. 📘🧪

👩‍🏫 Experience

Dr. Neda Shakour has over a decade of teaching experience at institutions like the Non-Profit Institute of the Role of the World in Isfahan, Shahreza University, and Borujen University. From 2021 to 2023, she worked as a postdoctoral researcher at Mashhad University of Medical Sciences, specializing in drug discovery. Currently, she is actively contributing to the Food and Drug Administration of Mashhad, where she applies her expertise in medicinal chemistry to enhance drug regulation and healthcare policies. 📚🔎

🏅 Awards and Honors

Dr. Neda Shakour was awarded the Level 3 Research and Innovation Credit by the National Elite Foundation in 2010. In 2024-2025, she secured prestigious research grants for two groundbreaking projects on non-peptide GLP-1R natural agonists and kidney failure treatments. Her consistent recognition for research excellence underscores her impact in drug discovery and diabetes management. With her dedication to innovation, Dr. Shakour remains a leader in medicinal chemistry research. 🥇🔬

🔍 Research Focus

Dr. Neda Shakour’s research spans the design, synthesis, and biological evaluation of organic compounds, particularly thiazolidinediones for diabetes treatment. She specializes in in silico drug discovery, biomimetic synthesis, and the development of targeted therapies for metabolic diseases. Her work also addresses cancer treatments and fibrosis management, demonstrating a commitment to improving patient outcomes. Dr. Shakour’s research significantly advances therapeutic innovation in pharmaceutical science. 💡🧪

Publication Top Notes

  • 📖 The natural phenolic compounds as modulators of NADPH oxidases in hypertension – Phytomedicine 55, 200-213 – Cited by: 176 – Year: 2019 🌿

  • 📖 Statins and C-reactive protein: in silico evidence on direct interaction – Archives of Medical Science 16 (6), 1432-1439 – Cited by: 60 – Year: 2020 💊

  • 📖 Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review – Pharmacological Properties of Plant-Derived Natural Products – Cited by: 35 – Year: 2021 🌱

  • 📖 Docetaxel encapsulation in nanoscale assembly micelles for targeted metastatic breast cancer therapy – International Journal of Pharmaceutics 605, 120822 – Cited by: 31 – Year: 2021 🧬

  • 📖 In silico evidence of direct interaction between statins and β‐amyloid – Journal of Cellular Biochemistry 120 (3), 4710-4715 – Cited by: 23 – Year: 2019 🧠

  • 📖 Cellulose-based nanofibril composite materials for bacterial infection control – Frontiers in Bioengineering and Biotechnology 9, 732461 – Cited by: 22 – Year: 2021 🦠

  • 📖 Design, synthesis and biological evaluation of novel thiazolidinediones as antidiabetic agents – Bioorganic Chemistry 115, 105162 – Cited by: 20 – Year: 2021 🍎

  • 📖 Data mining approaches to explore the association between type 2 diabetes mellitus with SARS-CoV-2 – BMC Pulmonary Medicine 23 (1), 1-14 – Cited by: 19 – Year: 2023 🩸

  • 📖 Candesartan inhibits tumor growth and fibrosis in colorectal cancer – Excli Journal 20, 863 – Cited by: 17 – Year: 2021 🧑‍⚕️

  • 📖 Dual targeting of TGF-β and PD-L1 in colorectal carcinoma – Life Sciences 328, 121865 – Cited by: 13 – Year: 2023 🧫